Philip Eaton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Philip Eaton has a total of 855 co-authors. Here are the top co-authors by number of shared publications:
- Joseph Robert Burgoyne
School of Cardiovascular and Metabolic Medicine & Sciences, King’s College London; The British Heart Foundation Centre of Excellence, The Rayne Institute, St Thomas’ Hospital, London, SE1 7EH, UK
33 shared publications Oleksandra Prysyazhna
William Harvey Research Institute, Queen Mary University of London, UK
24 shared publications- Michael J. Shattock
School of Cardiovascular and Metabolic Medicine and Sciences, BHF Centre of Research Excellence, King’s College London , London SE1 7EH
19 shared publications - Olena Rudyk
King's College London, Cardiovascular Division, The British Heart Foundation Centre of Excellence, The Rayne Institute, St Thomas' Hospital, London SE1 7EH, UK
15 shared publications Rebecca L. Charles
William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, EC1M6BQ, United Kingdom
13 shared publications- William Fuller
University of Glasgow
10 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (37)
Redox state of Protein Kinase A RIα coordinates lysosomal calcium signaling and mitochondrial homeostasis
Protein Kinase A (PKA) Regulatory RIα cysteine redox state regulates docking to D-AKAP1 and may control Drp1 phosphorylation, a principal mediator of mitochondrial fission. RIα C17S knock-in (KI) mice, unable to form disulfides and therefore mimicking the reduced kinase, exhibited enlarged dysfunctional mitochondria. Unexpectedly, this abnormal mitochondrial morphology, which was accompanied by reduced respiration, decreased membrane potential, increased reactive oxygen species and impaired treadmill performance, was not explained by altered Drp1 Ser637 phosphorylation. Transcriptomic analysis revealed decreased mitochondrial biogenesis without loss of total mitochondrial mass, consistent with impaired mitochondrial turnover. KI cells showed impaired lysosomal proteolysis, altered lysosomal calcium homeostasis, reduced RIα–lysosome colocalization and markedly diminished TRPML1 abundance. Pharmacological modulation of lysosomal calcium pathways restored lysosomal calcium signaling in KI cells, whereas activation of TRPML1 signaling impaired mitochondrial respiration in wildtype cells toward KI levels. Together, these findings support a role for disulfide-RIα in coordinating lysosomal calcium signaling and mitochondrial quality control, such that loss of this oxidation state promotes accumulation of dysfunctional mitochondria.
- 8 September 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (37)
Open AccessRedox state of Protein Kinase A RIα coordinates lysosomal calcium signaling and mitochondrial homeostasis
Protein Kinase A (PKA) Regulatory RIα cysteine redox state regulates docking to D-AKAP1 and may control Drp1 phosphorylation, a principal mediator of mitochondrial fission. RIα C17S knock-in (KI) mice, unable to form disulfides and therefore mimicking the reduced kinase, exhibited enlarged dysfunctional mitochondria. Unexpectedly, this abnormal mitochondrial morphology, which was accompanied by reduced respiration, decreased membrane potential, increased reactive oxygen species and impaired treadmill performance, was not explained by altered Drp1 Ser637 phosphorylation. Transcriptomic analysis revealed decreased mitochondrial biogenesis without loss of total mitochondrial mass, consistent with impaired mitochondrial turnover. KI cells showed impaired lysosomal proteolysis, altered lysosomal calcium homeostasis, reduced RIα–lysosome colocalization and markedly diminished TRPML1 abundance. Pharmacological modulation of lysosomal calcium pathways restored lysosomal calcium signaling in KI cells, whereas activation of TRPML1 signaling impaired mitochondrial respiration in wildtype cells toward KI levels. Together, these findings support a role for disulfide-RIα in coordinating lysosomal calcium signaling and mitochondrial quality control, such that loss of this oxidation state promotes accumulation of dysfunctional mitochondria.
- Open Access
- 24 March 2026
- Published by Elsevier in Redox Biology
- Vol. 92, 104136
A redox sensor in protein kinase A regulatory subunit Iα regulates vasodilation and protects against hypertension
- 24 March 2026
- Published by Elsevier in Redox Biology
- Vol. 92, 104136
Open AccessA redox sensor in protein kinase A regulatory subunit Iα regulates vasodilation and protects against hypertension
- Open Access
- 12 December 2025
- Published by Elsevier in Redox Biology
- Vol. 89, 103974
A novel inhibitor of soluble epoxide hydrolase that adducts C521 is cardioprotective
- 12 December 2025
- Published by Elsevier in Redox Biology
- Vol. 89, 103974
Open AccessA novel inhibitor of soluble epoxide hydrolase that adducts C521 is cardioprotective
- Open Access
- 15 October 2025
- Published by Elsevier in Redox Biology
- Vol. 87, 103894
Protein kinase GIα oxidation negatively regulates antibody production by B cells
- 15 October 2025
- Published by Elsevier in Redox Biology
- Vol. 87, 103894
Open AccessProtein kinase GIα oxidation negatively regulates antibody production by B cells
- 1 October 2025
- Published by American Physiological Society in Physiological Reviews
- Vol. 105 (4) , 2033-2072
Cysteine-based redox sensors in the cardiovascular system: from identification to physiology and drug discovery
Cysteine residues are uniquely equipped to sense redox signals because of the reactivity of their thiol side chains, which can undergo oxidation to form various modifications. By sensing changes within the intracellular redox environment, reactive cysteine thiols add a distinct shape and a charge characteristic that can induce protein conformational changes, ultimately triggering specific effector responses that alter cellular and tissue function. Redox sensing is essential within the cardiovascular system, where it regulates both cardiac and vascular function and significantly influences disease progression. This review provides a brief introduction to cysteine thiol redox sensors, outlines methodologies for their detection, and explores their roles in the cardiovascular system. Also discussed are recent advancements in identifying cysteine-targeted therapies and a proposal for a redefined perspective on the role of redox biology within the cardiovascular system.
- 1 October 2025
- Published by American Physiological Society in Physiological Reviews
- Vol. 105 (4) , 2033-2072
Cysteine-based redox sensors in the cardiovascular system: from identification to physiology and drug discovery
Cysteine residues are uniquely equipped to sense redox signals because of the reactivity of their thiol side chains, which can undergo oxidation to form various modifications. By sensing changes within the intracellular redox environment, reactive cysteine thiols add a distinct shape and a charge characteristic that can induce protein conformational changes, ultimately triggering specific effector responses that alter cellular and tissue function. Redox sensing is essential within the cardiovascular system, where it regulates both cardiac and vascular function and significantly influences disease progression. This review provides a brief introduction to cysteine thiol redox sensors, outlines methodologies for their detection, and explores their roles in the cardiovascular system. Also discussed are recent advancements in identifying cysteine-targeted therapies and a proposal for a redefined perspective on the role of redox biology within the cardiovascular system.
- Open Access
- 10 July 2025
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (8) , 2115-2136
SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2
Activating mutations of Src homology-2 domain-containing protein tyrosine phosphatase-2 (Shp2) cause multiple childhood conditions for which there is an unmet therapeutic need, including juvenile myelomonocytic leukemia (JMML) and Noonan syndrome. SFX-01, an α-cyclodextrin-stabilized sulforaphane complex currently in clinical development, covalently adducts cysteine residues. Using unbiased proteomics, its protein targets were identified, including Shp2. SFX-01 induced an inhibitory dithiolethione modification at the Shp2 active site cysteine. Importantly, in a transgenic mouse model of human Noonan syndrome with hyperactive D61G Shp2, SFX-01 concomitantly normalized their phosphatase activity and myeloid cell count. Furthermore, SFX-01 also attenuated JMML human patient-derived hematopoietic stem cell proliferation that was linked to STAT1 signaling and decreased cyclin D1 expression, resulting in cell-cycle arrest. We conclude that SFX-01 is an activating mutant Shp2 inhibitor and may offer beneficial effects in patients with JMML or Noonan syndrome.
- 10 July 2025
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (8) , 2115-2136
Open AccessSFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2
Activating mutations of Src homology-2 domain-containing protein tyrosine phosphatase-2 (Shp2) cause multiple childhood conditions for which there is an unmet therapeutic need, including juvenile myelomonocytic leukemia (JMML) and Noonan syndrome. SFX-01, an α-cyclodextrin-stabilized sulforaphane complex currently in clinical development, covalently adducts cysteine residues. Using unbiased proteomics, its protein targets were identified, including Shp2. SFX-01 induced an inhibitory dithiolethione modification at the Shp2 active site cysteine. Importantly, in a transgenic mouse model of human Noonan syndrome with hyperactive D61G Shp2, SFX-01 concomitantly normalized their phosphatase activity and myeloid cell count. Furthermore, SFX-01 also attenuated JMML human patient-derived hematopoietic stem cell proliferation that was linked to STAT1 signaling and decreased cyclin D1 expression, resulting in cell-cycle arrest. We conclude that SFX-01 is an activating mutant Shp2 inhibitor and may offer beneficial effects in patients with JMML or Noonan syndrome.
- 24 June 2025
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 137 (3) , 449-452
Exercise-Induced SOD3/H 2 O 2 Sulfenylates PKG1α to Restore Vasodilation in Diabetes
- 24 June 2025
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 137 (3) , 449-452
Exercise-Induced SOD3/H 2 O 2 Sulfenylates PKG1α to Restore Vasodilation in Diabetes
- Open Access
- 3 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
On the utility of immobilized phenylarsine oxide in the study of redox sensitive cardiac proteins
Reactive protein cysteine thiols are critical to sensing and transducing oxidant signals, often by induction of disulfide bonds that alter their activity or interactions. Identifying such redox active proteins nowadays is mostly achieved using thiol redox proteomics with such datasets increasingly available. Subsequently, we are challenged with determining how changes in the redox state of a protein of interest alters its activity or interactions and how this affects physiology or disease progression including in vivo scenarios. Such studies necessitate the measurement of how the protein redox state changes with health or disease-related interventions, with it not always being practicable to resort back to resource-intensive proteomics to achieve this. In some proteins, oxidation to a disulfide state causes a non-reducing gel-shift, but this is mostly not the case and so other efficient approaches are required to index changes in redox state. Here we assessed the utility of immobilized, solid-phase phenylarsine oxide (PAO-Sepharose) as a tool for indexing the thiol redox state of candidate proteins in cardiac samples from in vivo interventions associated with oxidative stress. PAO-Sepharose, which binds proteins with proximal reduced thiol pairs but not when they form a disulfide, was also used to identify proteins that that are oxidised in isolated perfused mouse hearts exposed to hydrogen peroxide or diamide using proteomics. This together with complementary studies using a cardiac-specific FLAG-Thioredoxin-1C35S-HA transgenic ‘trap-mutant’ mouse model allowed identification of heart proteins susceptible to oxidant-induced disulfide bond formation using proteomics. Thus, two in vitro approaches identified putative cardiac thiol redox sensor proteins that were then assessed with in vivo follow-up studies for their susceptibility to oxidation during endotoxemia induced by lipopolysaccharide or type I diabetes induced by streptozotocin in mice. Of five proteins selected for further analysis by PAO-Sepharose binding, two, namely apoptotic protease activating factor 1 interacting protein (APIP) and γ-glutamylcyclotransferase (GGCT), displayed significantly lower affinity capture from hearts from lipopolysaccharide- or streptozotocin-treated mice, consistent with oxidation of their vicinal thiols. We conclude that PAO-Sepharose is an effective and accessible tool for identifying oxidant-sensitive protein thiols in both ex vivo and in vivo models of oxidative stress. As increasing numbers of thiol redox proteins are identified, PAO-Sepharose binding is an efficient method to determine if they change their oxidation state during interventions relevant to health and disease.
- 3 May 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Open AccessOn the utility of immobilized phenylarsine oxide in the study of redox sensitive cardiac proteins
Reactive protein cysteine thiols are critical to sensing and transducing oxidant signals, often by induction of disulfide bonds that alter their activity or interactions. Identifying such redox active proteins nowadays is mostly achieved using thiol redox proteomics with such datasets increasingly available. Subsequently, we are challenged with determining how changes in the redox state of a protein of interest alters its activity or interactions and how this affects physiology or disease progression including in vivo scenarios. Such studies necessitate the measurement of how the protein redox state changes with health or disease-related interventions, with it not always being practicable to resort back to resource-intensive proteomics to achieve this. In some proteins, oxidation to a disulfide state causes a non-reducing gel-shift, but this is mostly not the case and so other efficient approaches are required to index changes in redox state. Here we assessed the utility of immobilized, solid-phase phenylarsine oxide (PAO-Sepharose) as a tool for indexing the thiol redox state of candidate proteins in cardiac samples from in vivo interventions associated with oxidative stress. PAO-Sepharose, which binds proteins with proximal reduced thiol pairs but not when they form a disulfide, was also used to identify proteins that that are oxidised in isolated perfused mouse hearts exposed to hydrogen peroxide or diamide using proteomics. This together with complementary studies using a cardiac-specific FLAG-Thioredoxin-1C35S-HA transgenic ‘trap-mutant’ mouse model allowed identification of heart proteins susceptible to oxidant-induced disulfide bond formation using proteomics. Thus, two in vitro approaches identified putative cardiac thiol redox sensor proteins that were then assessed with in vivo follow-up studies for their susceptibility to oxidation during endotoxemia induced by lipopolysaccharide or type I diabetes induced by streptozotocin in mice. Of five proteins selected for further analysis by PAO-Sepharose binding, two, namely apoptotic protease activating factor 1 interacting protein (APIP) and γ-glutamylcyclotransferase (GGCT), displayed significantly lower affinity capture from hearts from lipopolysaccharide- or streptozotocin-treated mice, consistent with oxidation of their vicinal thiols. We conclude that PAO-Sepharose is an effective and accessible tool for identifying oxidant-sensitive protein thiols in both ex vivo and in vivo models of oxidative stress. As increasing numbers of thiol redox proteins are identified, PAO-Sepharose binding is an efficient method to determine if they change their oxidation state during interventions relevant to health and disease.
- Open Access
- 8 December 2023
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 133 (12) , 966-988
Cyclin D-CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation
BACKGROUND: Pulmonary hypertension (PH) is a chronic vascular disease characterized, among other abnormalities, by hyperproliferative smooth muscle cells and a perturbed cellular redox and metabolic balance. Oxidants induce cell cycle arrest to halt proliferation; however, little is known about the redox-regulated effector proteins that mediate these processes. Here, we report a novel kinase-inhibitory disulfide bond in cyclin D-CDK4 (cyclin-dependent kinase 4) and investigate its role in cell proliferation and PH. METHODS: Oxidative modifications of cyclin D-CDK4 were detected in human pulmonary arterial smooth muscle cells and human pulmonary arterial endothelial cells. Site-directed mutagenesis, tandem mass-spectrometry, cell-based experiments, in vitro kinase activity assays, in silico structural modeling, and a novel redox-dead constitutive knock-in mouse were utilized to investigate the nature and definitively establish the importance of CDK4 cysteine modification in pulmonary vascular cell proliferation. Furthermore, the cyclin D-CDK4 oxidation was assessed in vivo in the pulmonary arteries and isolated human pulmonary arterial smooth muscle cells of patients with pulmonary arterial hypertension and in 3 preclinical models of PH. RESULTS: Cyclin D-CDK4 forms a reversible oxidant-induced heterodimeric disulfide dimer between C7/8 and C135, respectively, in cells in vitro and in pulmonary arteries in vivo to inhibit cyclin D-CDK4 kinase activity, decrease Rb (retinoblastoma) protein phosphorylation, and induce cell cycle arrest. Mutation of CDK4 C135 causes a kinase-impaired phenotype, which decreases cell proliferation rate and alleviates disease phenotype in an experimental mouse PH model, suggesting this cysteine is indispensable for cyclin D-CDK4 kinase activity. Pulmonary arteries and human pulmonary arterial smooth muscle cells from patients with pulmonary arterial hypertension display a decreased level of CDK4 disulfide, consistent with CDK4 being hyperactive in human pulmonary arterial hypertension. Furthermore, auranofin treatment, which induces the cyclin D-CDK4 disulfide, attenuates disease severity in experimental PH models by mitigating pulmonary vascular remodeling. CONCLUSIONS: A novel disulfide bond in cyclin D-CDK4 acts as a rapid switch to inhibit kinase activity and halt cell proliferation. This oxidative modification forms at a critical cysteine residue, which is unique to CDK4, offering the potential for the design of a selective covalent inhibitor predicted to be beneficial in PH.
- 8 December 2023
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 133 (12) , 966-988
Open AccessCyclin D-CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation
BACKGROUND: Pulmonary hypertension (PH) is a chronic vascular disease characterized, among other abnormalities, by hyperproliferative smooth muscle cells and a perturbed cellular redox and metabolic balance. Oxidants induce cell cycle arrest to halt proliferation; however, little is known about the redox-regulated effector proteins that mediate these processes. Here, we report a novel kinase-inhibitory disulfide bond in cyclin D-CDK4 (cyclin-dependent kinase 4) and investigate its role in cell proliferation and PH. METHODS: Oxidative modifications of cyclin D-CDK4 were detected in human pulmonary arterial smooth muscle cells and human pulmonary arterial endothelial cells. Site-directed mutagenesis, tandem mass-spectrometry, cell-based experiments, in vitro kinase activity assays, in silico structural modeling, and a novel redox-dead constitutive knock-in mouse were utilized to investigate the nature and definitively establish the importance of CDK4 cysteine modification in pulmonary vascular cell proliferation. Furthermore, the cyclin D-CDK4 oxidation was assessed in vivo in the pulmonary arteries and isolated human pulmonary arterial smooth muscle cells of patients with pulmonary arterial hypertension and in 3 preclinical models of PH. RESULTS: Cyclin D-CDK4 forms a reversible oxidant-induced heterodimeric disulfide dimer between C7/8 and C135, respectively, in cells in vitro and in pulmonary arteries in vivo to inhibit cyclin D-CDK4 kinase activity, decrease Rb (retinoblastoma) protein phosphorylation, and induce cell cycle arrest. Mutation of CDK4 C135 causes a kinase-impaired phenotype, which decreases cell proliferation rate and alleviates disease phenotype in an experimental mouse PH model, suggesting this cysteine is indispensable for cyclin D-CDK4 kinase activity. Pulmonary arteries and human pulmonary arterial smooth muscle cells from patients with pulmonary arterial hypertension display a decreased level of CDK4 disulfide, consistent with CDK4 being hyperactive in human pulmonary arterial hypertension. Furthermore, auranofin treatment, which induces the cyclin D-CDK4 disulfide, attenuates disease severity in experimental PH models by mitigating pulmonary vascular remodeling. CONCLUSIONS: A novel disulfide bond in cyclin D-CDK4 acts as a rapid switch to inhibit kinase activity and halt cell proliferation. This oxidative modification forms at a critical cysteine residue, which is unique to CDK4, offering the potential for the design of a selective covalent inhibitor predicted to be beneficial in PH.
- Open Access
- 11 January 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (3)
SOD1 is an essential H 2 S detoxifying enzyme
Although hydrogen sulfide (H 2 S) is an endogenous signaling molecule with antioxidant properties, it is also cytotoxic by potently inhibiting cytochrome c oxidase and mitochondrial respiration. Paradoxically, the primary route of H 2 S detoxification is thought to occur inside the mitochondrial matrix via a series of relatively slow enzymatic reactions that are unlikely to compete with its rapid inhibition of cytochrome c oxidase. Therefore, alternative or complementary cellular mechanisms of H 2 S detoxification are predicted to exist. Here, superoxide dismutase [Cu-Zn] (SOD1) is shown to be an efficient H 2 S oxidase that has an essential role in limiting cytotoxicity from endogenous and exogenous sulfide. Decreased SOD1 expression resulted in increased sensitivity to H 2 S toxicity in yeast and human cells, while increased SOD1 expression enhanced tolerance to H 2 S. SOD1 rapidly converted H 2 S to sulfate under conditions of limiting sulfide; however, when sulfide was in molar excess, SOD1 catalyzed the formation of per- and polysulfides, which induce cellular thiol oxidation. Furthermore, in SOD1-deficient cells, elevated levels of reactive oxygen species catalyzed sulfide oxidation to per- and polysulfides. These data reveal that a fundamental function of SOD1 is to regulate H 2 S and related reactive sulfur species.
- 11 January 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (3)
Open AccessSOD1 is an essential H 2 S detoxifying enzyme
Although hydrogen sulfide (H 2 S) is an endogenous signaling molecule with antioxidant properties, it is also cytotoxic by potently inhibiting cytochrome c oxidase and mitochondrial respiration. Paradoxically, the primary route of H 2 S detoxification is thought to occur inside the mitochondrial matrix via a series of relatively slow enzymatic reactions that are unlikely to compete with its rapid inhibition of cytochrome c oxidase. Therefore, alternative or complementary cellular mechanisms of H 2 S detoxification are predicted to exist. Here, superoxide dismutase [Cu-Zn] (SOD1) is shown to be an efficient H 2 S oxidase that has an essential role in limiting cytotoxicity from endogenous and exogenous sulfide. Decreased SOD1 expression resulted in increased sensitivity to H 2 S toxicity in yeast and human cells, while increased SOD1 expression enhanced tolerance to H 2 S. SOD1 rapidly converted H 2 S to sulfate under conditions of limiting sulfide; however, when sulfide was in molar excess, SOD1 catalyzed the formation of per- and polysulfides, which induce cellular thiol oxidation. Furthermore, in SOD1-deficient cells, elevated levels of reactive oxygen species catalyzed sulfide oxidation to per- and polysulfides. These data reveal that a fundamental function of SOD1 is to regulate H 2 S and related reactive sulfur species.